| 2015 | 2016 | Source | |
| Total population | 10858018 | 10855694 | Hellenic Statistical Authority [24] * |
| Prevalence | 1.2% | 1.2% | Hatzakis et al. 2015 [11] |
| Prevalent cases | 126713 | 126686 | |
| % of diagnosed patients | 20.0% | 20.0% | Papatheodoridis et al. 2015 [25] |
| Number of patients diagnosed | 25343 | 25337 | |
| % of G1 patients | 33% | 33% | Manolakopoulos et al. 2013 [26] |
| G1 patients | 8363 | 8361 | |
| % of Q80K patients | 2.3% | 2.3% | Expert panel data |
| Number of patients after excluding Q80K | 8169 | 8167 | |
| % of F0 - F2 patients | 70% | 70% | Expert panel data |
| F0 - F2 patient population | 5718 | 5717 | |
| % of treatment naïve patients at F0 - F2 | 65% | 65% | Expert panel data |
| Treatment naïve F0 - F2 patient population | 3717 | 3716 | |
| % of patients initiating treatment | 10.0% | 10.0% | Expert panel data^ |
| Patient population | 372 | 372 |